Rapid disease course in African Americans with multiple sclerosisKISTER, I; CHAMOT, E; JUBELT, B et al.Neurology. 2010, Vol 75, Num 3, pp 217-223, issn 0028-3878, 7 p.Article

GLANCE : Results of a phase 2, randomized, double-blind, placebo-controlled studyGOODMAN, A. D; ROSSMAN, H; PANZARA, M. A et al.Neurology. 2009, Vol 72, Num 9, pp 806-812, issn 0028-3878, 7 p.Article

An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex®) in patients with multiple sclerosisVOLLMER, T. L; PHILLIPS, J. T; GOODMAN, A. D et al.Multiple sclerosis. 2004, Vol 10, Num 5, pp 511-520, issn 1352-4585, 10 p.Article

Effects of fasting, feeding, and insulin on enhancing effect of GTP on cAMP binding in rat hepatic cytosolROSENBERG, E. M; GOODMAN, A. D; LIPINSKI, T. I et al.Diabetes (New York, NY). 1987, Vol 36, Num 1, pp 37-42, issn 0012-1797Article

Quantitative functional measures in MS: What is a reliable change?SCHWID, S. R; GOODMAN, A. D; MCDERMOTT, M. P et al.Neurology. 2002, Vol 58, Num 8, pp 1294-1296, issn 0028-3878Article

Are quantitative functional measures more sensitive to worsening MS than traditional measures?SCHWID, S. R; GOODMAN, A. D; APATOFF, B. R et al.Neurology. 2000, Vol 55, Num 12, pp 1901-1903, issn 0028-3878Article

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosisSCHWID, S. R; PETRIE, M. D; MCDERMOTT, M. P et al.Neurology. 1997, Vol 48, Num 4, pp 817-821, issn 0028-3878Article

The measurement of ambulatory impairment in multiple sclerosisSCHWID, S. R; GOODMAN, A. D; MATTSON, D. H et al.Neurology. 1997, Vol 49, Num 5, pp 1419-1424, issn 0028-3878Article

Autonomic neuropathy associated with autoimmune diseaseGUDESBLATT, M; GOODMAN, A. D; RUBENSTEIN, A. E et al.Neurology. 1985, Vol 35, Num 2, pp 261-264, issn 0028-3878Article

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the I5-year analysis of the US prospective open-label study of glatiramer acetateFORD, C; GOODMAN, A. D; PRUITT, A et al.Multiple sclerosis. 2010, Vol 16, Num 3, pp 342-350, issn 1352-4585, 9 p.Article

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumWEINSTOCK-GUTTMAN, B; JACOBS, L. D; GOTTESMAN, M. H et al.Multiple sclerosis. 2003, Vol 9, Num 3, pp 293-298, issn 1352-4585, 6 p.Article

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trialJOHNSON, K. P; BROOKS, B. R; WOLINSKY, J. S et al.Multiple sclerosis. 2003, Vol 9, Num 6, pp 585-591, issn 1352-4585, 7 p.Article

Benefit of interferon β-1a on MSFC progression in secondary progressive MSCOHEN, J. A; CUTTER, G. R; TSAO, E. C et al.Neurology. 2002, Vol 59, Num 5, pp 679-687, issn 0028-3878Article

Suppresive effect of glucose administration on the binding of prolactin by rat liverGOODMAN, A. D; HOEKSTRA, S; MONAHAN, J. W et al.Metabolism, clinical and experimental. 1990, Vol 39, Num 6, pp 568-576, issn 0026-0495, 9 p.Article

Hypertension and hyperparathyroidism. Inverse relation of serum phosphate level and blood pressureDANIELS, J; GOODMAN, A. D.The American journal of medicine. 1983, Vol 75, Num 1, pp 17-23, issn 0002-9343Article

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeksMORROW, S. A; O'CONNOR, P. W; BENEDICT, Rhb et al.Multiple sclerosis. 2010, Vol 16, Num 11, pp 1385-1392, issn 1352-4585, 8 p.Article

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MSCOHEN, J. A; IMREY, P. B; HUTTON, G. J et al.Neurology. 2009, Vol 72, Num 6, pp 535-541, issn 0028-3878, 7 p.Article

Dose comparison trial of sustained-release fampridine in multiple sclerosisGOODMAN, A. D; BROWN, T. R; COHEN, J. A et al.Neurology. 2008, Vol 71, Num 15, pp 1134-1141, issn 0028-3878, 8 p.Article

Quantitative assessment of motor fatigue and strength in MSSCHWID, S. R; THORNTON, C. A; PANDYA, S et al.Neurology. 1999, Vol 53, Num 4, pp 743-750, issn 0028-3878Article

Frequency of anti-nuclear antibodies in multiple sclerosisBARNED, S; GOODMAN, A. D; MATTSON, D. H et al.Neurology. 1995, Vol 45, Num 2, pp 384-385, issn 0028-3878Article

The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T₃) toxicosisFIGGE, J; LEINUNG, M; GOODMAN, A. D et al.The American journal of medicine. 1994, Vol 96, Num 3, pp 229-234, issn 0002-9343Article

Rapid onset of severe retinopathy, cataracts and neuropathy in young patients with diabetes mellitusCARROLL, P. B; HERSKOWITZ, R. D; GOODMAN, A. D et al.Acta paediatrica (Oslo). 1992, Vol 81, Num 4, pp 355-358, issn 0803-5253Article

Evidence for the existence of a GTP-dependent factor in hepatic cytosol that stimulates cyclic AMP binding: possible role in the modulation of cyclic AMP actionROSENBERG, E. M; GOODMAN, A. D; LIPINSKI, T. L et al.Metabolism, clinical and experimental. 1989, Vol 38, Num 9, pp 916-920, issn 0026-0495Article

Suppressive effect of inflammation and other forms of stress on the binding of prolactin by rat liverGOODMAN, A. D; HOEKSTRA, S; MONAHAN, J. W et al.Endocrinology (Philadelphia). 1985, Vol 116, Num 2, pp 835-842, issn 0013-7227Article